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Abstract 
An experiment was conducted to determine the adjuvanticity of recombinant bovine interleukin-1Î² 
(rBoIL-1Î²) and recombinant bovine interleukin-2 (rBoIL-2) administered in conjunction with a single S. suis 
vaccination in pigs. Sixty, 4-wk-old pigs were allotted to 8 groups: 1) nonvaccinated controls; 2) 
vaccinated controls; 3) rBoIL-IÎ², 100 ng/kg; 4)rBoIL-lÎ², 1000 ng/kg; 5) rBoIL-1Î², 10,000 ng/kg; 6) rBoIL-2, 
2.5 Âµg/kg; 7) rBoIL-2, 25 Âµg/kg; and 8) rBoIL-2, 250 Âµg/kg. All pigs (except group 1) were vaccinated 
on d 0 with a commercial S. suis vaccine (serotypes 1 and 2). At vaccination, pigs were injected 
intramuscularly with their respective cytokine treatments. Pigs received additional cytokine injections for 
2 consecutive days. On d 21, all pigs were injected intravenously with 3.5 x 109 CFU of a log phase culture 
of S. suis (serotype 2). The highest dose of rBolL-1Î² exceeded the maximum tolerable dose for the 
cytokine; however, this dose of rBoIL-1Î² protected pigs from the S. suis challenge. In pigs receiving 
rBoIL-1Î² at 10,000 ng/kg, pathological lesions caused by S. suis were lowest when compared to other 
treatment groups. No mortality from S. suis challenge was observed in pigs that received the highest 
dose of rBoIL-1Î². These data clearly show that rBoIL-1Î² (10,000 ng/kg), administered intramuscularly for 
3 consecutive days at vaccination, is more effective than the S. suis vaccine alone in protecting pigs 
against a S. suis challenge.; Swine Day, Manhattan, KS, November 21, 1991 
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